Wednesday, September 16, 2020 11:05:46 PM
A lot of us that got into the stock years ago believe in the Product.
I think it is cutting edge.
But still - no results or revenue coming up on 2 years since FDA approval.
Why should we believe a deal is imminent now..?
Their most basic product dumbed down is an external band-aid.
And that is a huge market.
Unfortunately a number of other products similar to that came on the scene while Norchi was dinking around with this and that.
That marketing deal was supposed to be their financial golden ticket to pay for all the work to get the really great products approved and sold.
And he blew it.
Look at the above example.
Great results.....
But it costs 4 doctor room visits to get it done.
This is still a great product.....
But I think dilution will take the stock price into the single digits.
In which case I might get back in.
Recent ARTH News
- Form 8-K - Current report • Edgar (US Regulatory) • 09/26/2024 09:00:11 PM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM
Unitronix Corp Unveils Cryptocurrency Investment Portfolio Strategy • UTRX • Oct 2, 2024 8:40 AM
Integrated Ventures, Inc Reports Total 2024 Revenues Of $5,863,935 vs $3,862,849 for 2023. • INTV • Oct 1, 2024 9:00 AM
Nightfood Signs Letter of Intent to Acquire Los Angeles Cooking School, Integrating Automation and Robotics with World-Class Culinary Training • NGTF • Oct 1, 2024 8:30 AM
ZenaTech, Inc. (NASDAQ: ZENA) To Commence Trading Today • COOP • Oct 1, 2024 7:00 AM
Element79 Gold Corp secures loi for launching tailings reprocessing business in Arequipa, Peru • ELMGF • Oct 1, 2024 6:38 AM